Recipient of the 2020-2021 Dr. Margaret Becklake Fellowship: Mikashmi Kohli
A postdoctoral fellow from the RI-MUHC is recognized for international work on TB diagnostics
Three COVID-19 projects at the RI-MUHC to receive CIHR funding
A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease
Rifampin for Latent TB: Shorter and safer than the standard treatment, but also cheaper
A new study shows that rifampin regimen is cheaper than isoniazid for latent tuberculosis
Why do some non-smokers get COPD while many heavy smokers don’t?
A new study highlights a strong risk factor for COPD related to lung development
Results of MI4 Emergency COVID-19 Research Funding (Round 2)
RI-MUHC researchers awarded MUHC Foundation funding for a second round of projects with potential impact in a short timeframe
We Care About Rare!
Researchers, advocates and patients gather on Rare Disease Research Day at the RI-MUHC
RI-MUHC investigator joins Global Consortium of Chemosensory Researchers (GCCR) in rapid response to COVID-19
GCCR group develops worldwide survey on smell loss
Results of MI4 Emergency COVID-19 Research Funding (Round 1)
RI-MUHC researchers awarded MUHC Foundation funding for projects with potential impact in a short timeframe
FRQ to create a province-wide COVID-19 Biobank
RI-MUHC researchers take leading roles in the initiative
The Pfizer Investigator Training Program comes to the RI-MUHC!
Clinical research educational training program benefits researchers, staff and students at the inaugural event